07 Jan 2001

Tavor® 0,5 (Tavor® 0,5/-1,0/-2,5 Tabletten) - Deutschland

Updated: 07 Jan 2001

Tavor® 0,5 | -1,0 | -2,5; -1,0 | -2,5 Expidet; -Tabs 2,0

Symptomat. Behandl. akuter u. chron. Angst-, Spannungs- u. Erregungszustände u. dadurch bedingter Schlafstör. Sedierung vor diagnostischen sowie vor u. nach operativen Eingriffen.

Tavor® 0,5 Description, Presentation and Dosage

Tavor® 0,5 Description

Tavor® 0,5 Drug Class Description

Mittellangwirksame Benzodiazepine (6-24h)

Tavor® 0,5 Drug Description

1 Tbl. enth.: Lorazepam 0,5 mg/1 mg/2,5 mg.

Tavor® 0,5 Generic Name

Tavor® 0,5/-1,0/-2,5 Tabletten

Tavor® 0,5 Presentation

Tavor® 0,5 Presentation

Tavor® 0,5/-1,0/-2,5; -1,0/-2,5 Expidet; -Tabs 2,0

Tavor® 0,5 Manufacturer

Wyeth

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Tavor® 0,5 Dosage

Tavor® 0,5 Adult Dosage

Lactose 1H2O, Polacrilin-Kalium, Magnesiumstearat, mikrokristalline Cellulose, Tavor 0,5 zusätzlich: Farbstoff E 132, Tavor 2,5 zusätzlich: Farbstoffe E 104, E 172.

Tavor® 0,5 Child Dosage


Tavor® 1,0/-2,5 Expidet lyophilisierte Plättchen
Zus.: 1 Plättchen enth.: Lorazepam 1 mg/2,5 mg.
Weit. Bestandteile: Gelatine, D-Mannitol.

Tavor® Tabs 2,0 Tabletten
Zus.: 1 Tbl. enth.: Lorazepam 2 mg.
Weit. Bestandteile: Lactose 1H2O, mikrokristalline Cellulose, Polacrilin-Kalium, Magnesiumstearat, Farbstoff E 104, E 172.

Tavor® 0,5 Precautions, Reactions and Contraindications

Tavor® 0,5 Special Precautions

Tavor® 0,5 Special Precautions

B 10 a-c

Tavor® 0,5 Adverse Reactions

Tavor® 0,5 Adverse Reactions

B 10

Related Drugs - Psychiatry/Mental Health

Back to top